美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Carvedilol Phosphate	Capsule (Extended Release)	II (Paddle)	100	0.1 N HCl	900	1, 2, 4, 6, 8, 12, 18 and 24 hours	2013/10/31
Cedazuridine/Decitabine	Tablet	II (Paddle)	75	50 mM phosphate buffer, pH 6.8	900	5, 10, 15 and 30	2022/07/07
Cefaclor	Tablet (Chewable)			Develop a dissolution method			2024/01/03
Cefaclor	Tablet (Extended Release)			Refer to USP			2011/03/03
Cefaclor	Capsule			Develop a dissolution method			2024/01/03
Cefadroxil	Tablet			Develop a dissolution method			2024/01/03
Cefadroxil	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Cefadroxil	Suspension			Develop a dissolution method			2023/09/15
Cefdinir	Capsule	II (Paddle)	50	Phosphate Buffer, pH 6.8	900	5, 10, 15, 30 and 45	2007/07/25
Cefdinir	Suspension	II (Paddle)	50	0.05 M Phosphate buffer, pH 6.8	900	10, 20, 30 and 45	2007/04/09
Cefditoren Pivoxil	Tablet	II (Paddle)	75	Simulated Gastric Fluid without enzyme	900	5, 10, 15, 20 and 30	2010/01/15
Cefixime	Suspension	II (Paddle)	50	0.05 M Phosphate buffer, pH 7.2	900	10, 20, 30 and 45	2007/04/09
Cefixime	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Cefixime	Tablet (Chewable)	II (Paddle	25	Phosphate Buffer, pH 7.2	900	10, 15, 20, 30, and 45	2010/12/23
Cefixime	Capsule	I (Basket)	100	0.05 M Phosphate Buffer, pH 7.2	900	10, 20, 30, 45 and 60	2013/08/15
Cefpodoxime Proxetil	Suspension	II (Paddle)	50	Glycine Buffer (0.04 M) pH 3.0	900	10, 20, 30 and 45	2005/12/20
Cefpodoxime Proxetil	Tablet			Refer to USP			2007/07/25
Cefprozil	Tablet			Develop a dissolution method			2024/01/03
Cefprozil	For Oral Suspension			Develop a dissolution method			2023/09/15
Cefprozil Monohydrate	Suspension			Develop a dissolution method			2023/09/15